MedTrace Logo

Cerebrovascular Autoregulation During and After Liver Transplantation

NCT01597102 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-06-11

No results posted yet for this study

Summary

The cerebrovascular autoregulation (AR) is impaired in patients with hepatic encephalopathy. Patients with the indication to liver transplantation mostly have mild to severe hepatic encephalopathy. Transplantation should recover the encephalopathy. The aim of the study is to investigate the AR during liver transplantation, with the questions if the AR is impaired at the beginning of surgery and if there are changes in AR. For follow up the AR will be measured at the first days after transplantation at the ICU.

Conditions

  • Encephalopathy, Hepatic
  • Cerebrovascular Disorders
  • Liver Failure

Interventions

OTHER

No interventions

No intervention is planned in this study

Sponsors & Collaborators

  • Johannes Gutenberg University Mainz

    lead OTHER

Principal Investigators

  • Patrick Schramm, MD · Johannes Gutenberg University Mainz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-08
Primary Completion
2020-12-31
Completion
2021-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597102 on ClinicalTrials.gov